Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
MTE03 - Neuroendocrine Tumours of the Lung
- Type: Meet the Expert (ticketed session)
- Track: Medical Oncology
- Presentations: 1
- Moderators:N. n/a
- Coordinates: 10/28/2013, 07:00 - 08:00, Bayside 106, Level 1
-
+
MTE03.1 - Neuroendocrine Tumours of the Lung
07:00 - 08:00 | Author(s): J. Guigay
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE04 - Submit Your Challenging Cases for Discussion & Debate!
- Type: Meet the Expert (ticketed session)
- Track: Pathology
- Presentations: 3
- Moderators:E. Duhig
- Coordinates: 10/28/2013, 07:00 - 08:00, Bayside 105, Level 1
-
+
Cases
08:00 - 08:20 | Author(s): E. Duhig
- Abstract
No abstract available for this presentation
-
+
MTE04.1 - Submit Your Challenging Cases for Discussion & Debate!
07:00 - 07:30 | Author(s): A.G. Nicholson
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE04.2 - Submit Your Challenging Cases for Discussion & Debate!
07:30 - 08:00 | Author(s): K. Jones
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE05 - Navigation Bronchoscopy
- Type: Meet the Expert (ticketed session)
- Track: Pulmonology + Endoscopy/Pulmonary
- Presentations: 1
- Moderators:N. n/a
- Coordinates: 10/28/2013, 07:00 - 08:00, Bayside 104, Level 1
-
+
MTE05.1 - Navigation Bronchoscopy
07:00 - 08:00 | Author(s): T. Ishida
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE06 - Molecular Pathology Approach for Early Clinical Stage Mesothelioma: Cytological Diagnosis, and Reactive Mesothelial Hyperplasia
- Type: Meet the Expert (ticketed session)
- Track: Mesothelioma
- Presentations: 1
- Moderators:N. n/a
- Coordinates: 10/28/2013, 07:00 - 08:00, Bayside 103, Level 1
-
+
MTE06.1 - Molecular Pathology Approach for Early Clinical Stage Mesothelioma: Cytological Diagnosis, and Reactive Mesothelial Hyperplasia
07:00 - 08:00 | Author(s): S. Klebe
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE07 - Chest Wall Recon: Materials, Artificial Ribs
- Type: Meet the Expert (ticketed session)
- Track: Surgery
- Presentations: 1
- Moderators:N. n/a
- Coordinates: 10/28/2013, 07:00 - 08:00, Bayside 102, Level 1
-
+
MTE07.1 - Chest Wall Recon: Materials, Artificial Ribs
07:00 - 08:00 | Author(s): M.J. Weyant
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE08 - Smoking Cessation
- Type: Meet the Expert (ticketed session)
- Track: Prevention & Epidemiology
- Presentations: 1
- Moderators:N. n/a
- Coordinates: 10/28/2013, 07:00 - 08:00, Bayside 101, Level 1
-
+
MTE08.1 - Smoking Cessation
07:00 - 08:00 | Author(s): N.A. Rigotti
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
PL02 - Will Personalised Therapies Ever “Cure” Metastatic NSCLC?
- Type: Plenary Session
- Track: Medical Oncology
- Presentations: 5
- Moderators:D. Gandara
- Coordinates: 10/28/2013, 08:15 - 09:45, Plenary Hall, Ground Level
-
+
PL02.0 - Chair Intro
08:15 - 08:20 | Author(s): D. Gandara
- Abstract
No abstract available for this presentation
-
+
PL02.1 - Identifying Druggable Targets Through Whole Genome Sequencing: TCGA
08:20 - 08:40 | Author(s): M. Meyerson
- Abstract
No abstract available for this presentation
-
+
PL02.2 - Dark Matter: Defining Oncogenic Drivers in the Epigenome
08:40 - 09:00 | Author(s): C.M. Rudin
- Abstract
Loading... -
+
PL02.3 - Tumour Heterogeneity as an Obstacle to Cure
09:00 - 09:20 | Author(s): C. Swanton
- Abstract
Loading... -
+
PL02.4 - What is Cure and How Can We Achieve This With Targeted Therapies?
09:20 - 09:40 | Author(s): T. Mok
- Abstract
No abstract available for this presentation
-
+
P1.01 - Poster Session 1 - Cancer Biology
- Type: Poster Session
- Track: Biology
- Presentations: 27
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.01-001 - VEGF is an autocrine survival factor in non-small cell lung cancer, mediating its effects via the Neuropilin-1 receptor.
09:30 - 09:44 | Author(s): M.P. Barr
- Abstract
Loading... -
+
P1.01-002 - Clinicopathological and biological significance of epiregulin expression in non-small cell lung cancer
09:44 - 09:58 | Author(s): N. Sunaga
- Abstract
Loading... -
+
P1.01-003 - Targeting EMT in lung cancer: An integrated analysis of Axl and other mesenchymal targets in The Cancer Genome Atlas (TCGA)
09:58 - 10:12 | Author(s): L.A. Byers
- Abstract
Loading... -
+
P1.01-004 - Role of the extracellular matrix in variations of invasive pathways in lung cancers
10:12 - 10:26 | Author(s): V.K. De Sa
- Abstract
Loading... -
+
P1.01-005 - EGFR and KRAS mutations in patients having lung adenocarcinoma associated with human papilloma virus infection
10:26 - 10:40 | Author(s): A.F. Cardona
- Abstract
Loading... -
+
P1.01-006 - Intra-tumor pressure of lung cancer may correlate tumor aggressiveness
10:40 - 10:54 | Author(s): T. Mori
- Abstract
Loading... -
+
P1.01-007 - Antimetastatic activity of ganetespib: preclinical studies and assessment of new lesion growth in the GALAXY-1 NSCLC trial
10:54 - 11:08 | Author(s): D.A. Proia
- Abstract
Loading... -
+
P1.01-008 - Inhibition of Binding at Exon 4 of Osteopontin Increases Apoptosis and Apoptotic Protein Expression in Non-Small Cell Lung Cancer
11:08 - 11:22 | Author(s): C. Goparaju
- Abstract
Loading... -
+
P1.01-009 - The Role of Autophagy Induced by Tyrosine Kinase Inhibitors in Non-small Cell Lung Carcinoma
11:22 - 11:36 | Author(s): Y.Y. Li
- Abstract
Loading... -
+
P1.01-010 - Heterogeneity of biomarkers between the primary tumor and the metastatic lymph nodes in non-small cell lung cancer
11:36 - 11:50 | Author(s): K. Shimizu
- Abstract
Loading... -
+
P1.01-011 - Targeting the Urokinase Plasminogen Activator (uPA) System to overcome cisplatin resistance in NSCLC
11:50 - 12:04 | Author(s): P. Godwin
- Abstract
Loading... -
+
P1.01-012 - The KDM6 Lysine Demethylases are candidate therapeutic targets in Malignant Pleural Mesothelioma
12:04 - 12:18 | Author(s): S. Cregan
- Abstract
Loading... -
+
P1.01-013 - Differences in gene expression profiles and carcinogenesis pathways in cisplatin resistance of four cancers
12:18 - 12:32 | Author(s): Y. Yang
- Abstract
Loading... -
+
P1.01-014 - Effects of combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor and the histone deacetylase inhibitor on NSCLC cells.
12:32 - 12:46 | Author(s): T. Takashina
- Abstract
Loading... -
+
P1.01-015 - Overabundance of activated stromal fibroblasts (TAFs) in NSCLC on response to extracellular matrix (ECM) rigidity
12:46 - 13:00 | Author(s): N. Reguart
- Abstract
Loading... -
+
P1.01-016 - Targeting NF-κB regulated pathways to overcome cisplatin resistance in non small cell lung cancer
13:00 - 13:14 | Author(s): A. Baird
- Abstract
Loading... -
+
P1.01-017 - The retain of extrapulmonary administered colloidal carbon in the mediastinal lymphnodes of Wistar rat
13:14 - 13:28 | Author(s): M. Sobotka
- Abstract
Loading... -
+
P1.01-018 - Epidermal growth factor up-regulates CD151 protein expression to promote non-small cell lung cancer proliferation
13:28 - 13:42 | Author(s): C.Y. Chin
- Abstract
Loading... -
+
P1.01-019 - Study of aberrant copy number of genes in adenocarcinoma of lung in never-smokers with respect to EGFR mutations by multiplex ligation-dependent probe amplification (MLPA®)
13:42 - 13:56 | Author(s): J.S. Au
- Abstract
Loading... -
+
P1.01-020 - Expression profile of serotonin 2B receptor (HTR2B) in non-small-cell lung cancer
13:56 - 14:10 | Author(s): H. Yokouchi
- Abstract
Loading... -
+
P1.01-021 - Class III beta-tubulin expression in non-small cell lung cancer as a predictive marker for paclitaxel.
14:10 - 14:24 | Author(s): T. Ohashi
- Abstract
Loading... -
+
P1.01-022 - Calbindin-D28k expression is correlated with the organotropism of lung cancer adrenal metastasis.
14:24 - 14:38 | Author(s): T. Yoshimasu
- Abstract
Loading... -
+
P1.01-023 - The expression of ATBF1 is inversely proportion to the expression of estrogen receptor in lung cancer cells
14:38 - 14:52 | Author(s): M. Inoue
- Abstract
Loading... -
+
P1.01-024 - Evaluation of Vascular Normalization in Human Lung Adenocarcinoma Induced by EGCG and the Efficacy of Combine Chemotherapy in Its Normalization Time Window
14:52 - 15:06 | Author(s): P.B. Deng
- Abstract
Loading... -
+
P1.01-025 - Apoptosis-Related Gene Transcription in Human A549 Lung Cancer Cells via A3 Adenosine Receptor
15:06 - 15:20 | Author(s): H. Kamiya
- Abstract
Loading... -
+
P1.01-026 - Pro-tumorigenic alteration of signalling pathways in normal mesothelium: Contribution of non-mesothelial cells in malignant mesothelioma carcinogenesis
15:20 - 15:34 | Author(s): T. Chernova
- Abstract
Loading... -
+
P1.01-027 - Long non-coding RNAs: a new frontier in the study of human diseases
15:34 - 15:48 | Author(s): Y. Song
- Abstract
Loading...
-
+
P1.02 - Poster Session 1 - Novel Cancer Genes and Pathways
- Type: Poster Session
- Track: Biology
- Presentations: 22
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.02-001 - A common polymorphism in pre-microRNA-146a is associated with lung cancer risk in a Korean population
09:30 - 09:30 | Author(s): H. Jeon
- Abstract
Loading... -
+
P1.02-002 - ATM deficiency increases radiation sensitivity in NSCLC cell lines in vitro and confers a poor outcome in early resected NSCLC.
09:30 - 09:30 | Author(s): G. Bebb
- Abstract
Loading... -
+
P1.02-003 - Synergetic study of chemotherapeutic drugs according to ATM status in NSCLC cell lines
09:30 - 09:30 | Author(s): R.A. Yee
- Abstract
Loading... -
+
P1.02-004 - Differential pathway disruption in lung adenocarcinomas from current and never smokers - A multi-omics data integration analysis
09:30 - 09:30 | Author(s): K.L. Thu
- Abstract
Loading... -
+
P1.02-005 - Prognostic role of expression levels of FABP3, H19, TFPI2, AKR1B10 CYP3A5, SCGB3A2 genes in adenocarcinoma stage I patients
09:30 - 09:30 | Author(s): V. Ludovini
- Abstract
Loading... -
+
P1.02-006 - Identification of targetable driver mutations in molecularly selected never smoker lung adenocarcinomas
09:30 - 09:30 | Author(s): C. Bennati
- Abstract
Loading... -
+
P1.02-007 - Validation and Function of a Novel miRNA signature in Cisplatin Resistant Non-Small Cell Lung Cancer Cells
09:30 - 09:30 | Author(s): L.A. Mac Donagh
- Abstract
Loading... -
+
P1.02-008 - hSSB1: an essential regulator of genomic integrity in lung cancer
09:30 - 09:30 | Author(s): M.N. Adams
- Abstract
Loading... -
+
P1.02-009 - KCTD11 methylation in non-adenocarcinoma lung cancer
09:30 - 09:30 | Author(s): J. Ni
- Abstract
Loading... -
+
P1.02-010 - Evaluation of the oncogenic ability of EML4-ALK to transform human bronchial epithelial cells (HBECs)
09:30 - 09:30 | Author(s): S. Kajikawa
- Abstract
Loading... -
+
P1.02-011 - RANK and RANK Ligand (RANKL) expression in primary human lung cancer
09:30 - 09:30 | Author(s): D. Branstetter
- Abstract
Loading... -
+
P1.02-012 - Paracrine receptor activation by microenvironment as a mechanism of RET inhibitor resistance in CCDC6-RET lung cancer cells
09:30 - 09:30 | Author(s): H. Chang
- Abstract
Loading... -
+
P1.02-013 - SDHB is overexpressed and may be a candidate target for therapeutic intervention in Malignant Pleural Mesothelioma
09:30 - 09:30 | Author(s): C.J. Jennings
- Abstract
Loading... -
+
P1.02-014 - The Gene-Expression Profiles in advanced lung Adenocarcinoma associated with Wood Smoke or tobbacco exposure are different in brain metastasis
09:30 - 09:30 | Author(s): A.O. Gomez
- Abstract
Loading... -
+
P1.02-015 - Diverse effects of PAI-1 proteins on lung and prostate cancer cell invasion.
09:30 - 09:30 | Author(s): J. Chorostowska-Wynimko
- Abstract
Loading... -
+
P1.02-016 - Non-small cell lung cancer and EGFR mutation in Poland - preliminary results from single institution study
09:30 - 09:30 | Author(s): A. Szumera-Cieckiewicz
- Abstract
Loading... -
+
P1.02-017 - NLBP (novel-LZAP binding protein) promotes the proliferation of lung adenocarcinoma cells through the regulation of p120 catenin
09:30 - 09:30 | Author(s): H. Nam
- Abstract
Loading... -
+
P1.02-018 - the wnt signaling pathway in lung carcinoid
09:30 - 09:30 | Author(s): R. Garcia Campelo
- Abstract
Loading... -
+
P1.02-019 - c-Met expression in unresectable or stage IV chemonaive adenocarcinoma of the lung and its co-existence with other driven mutations or genetic abnormalities.
09:30 - 09:30 | Author(s): E.S. Santos
- Abstract
Loading... -
+
P1.02-020 - Evaluation Of Gene Expression Profiles For The Differential Diagnosis Of Lung Adenocarcinoma and Malignant Pleural Mesothelioma
09:30 - 09:30 | Author(s): G. Omeroglu Simsek
- Abstract
Loading... -
+
P1.02-021 - Overexpression of αB-Crystallin predicts poor prognosis in Non-small-cell lung cancer
09:30 - 09:30 | Author(s): J. Gu
- Abstract
Loading... -
+
P1.02-022 - Downregulation of PAX6 by siRNA Inhibits Proliferation and Cell Cycle Progression of Human Non-Small Cell lung Cancer Cell Lines
09:30 - 09:30 | Author(s): X. Zhao
- Abstract
Loading...
-
+
P1.03 - Poster Session 1 - Technology and Novel Development
- Type: Poster Session
- Track: Biology
- Presentations: 6
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.03-001 - Multiplexing technology for in situ biomarker profiling of Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Author(s): A. Sood
- Abstract
Loading... -
+
P1.03-002 - Multiplexed analysis of lung cancer for distinguishing adenocarcinoma from squamous cell carcinoma
09:30 - 09:30 | Author(s): L.S. Kaanumalle
- Abstract
Loading... -
+
P1.03-003 - Novel detection method for EGFR T790M mutation by Eprobe mediated PCR and melting curve analysis
09:30 - 09:30 | Author(s): J. Atsumi
- Abstract
Loading... -
+
P1.03-004 - Robust Global microRNA Expression Profiling Using Next-Generation Sequencing Technologies
09:30 - 09:30 | Author(s): S. Tam
- Abstract
Loading... -
+
P1.03-005 - High throughput array and sensitive mass spectrometry technology applied to Transbronchial Needle Aspiration allow the (detection of hundreds molecular targets) tumor profiling for routine care personalized medicine
09:30 - 09:30 | Author(s): A. Izadifar
- Abstract
Loading... -
+
P1.03-006 - The efficiency of detection of KRAS, EGFR and BRAF mutations in primary lung cancer via peripheral blood circulating tumour cells
09:30 - 09:30 | Author(s): M.B. Freidin
- Abstract
Loading...
first
prev
